Samarth Kulkarni
CIK 1682019 · Chief Executive Officer · last filed 2026-06-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$16.22M
Companies
6
Total Filings
123
Lifetime Open-Market Net
-$65.03M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDTX | Director | — | $1.66 | — | $0 | 7 | 2026-06-29 |
| Centessa Pharmaceuticals plc (CNTA) Delisted | Director | — | $40.50 | — | $0 | 5 | 2026-06-24 |
| ORKA | Director | — | $87.35 | — | $0 | 2 | 2026-06-03 |
| CRSP | Chief Executive Officer | 341,123 | $47.55 | $16.22M | -$64.02M | 87 | 2026-03-24 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | — | $2.65 | — | $0 | 4 | 2024-06-20 |
| CRISPR Therapeutics AG (PZRX) Delisted | Chief Executive Officer | 148,560 | — | — | -$1.01M | 7 | 2017-12-26 |
Recent Filings · Page 2 of 13
123 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-22 | CRSP | Gift (G) | −30,000 | $0 | EDGAR |
| 2025-10-20 | CRSP | Mixed | +49,105 | -$3.46M | EDGAR |
| 2025-10-15 | CRSP | Mixed | +4,092 | -$282.5K | EDGAR |
| 2025-10-03 | CRSP | Grant (A) | — | $0 | EDGAR |
| 2025-09-19 | CRSP | Gift (G) | −6,000 | $0 | EDGAR |
| 2025-08-19 | CRSP | Mixed | +11,919 | -$760.7K | EDGAR |
| 2025-06-24 | Centessa Pharmaceuticals plc (CNTA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-12 | BDTX | Grant (A) | — | $0 | EDGAR |
| 2025-06-03 | ORKA | Grant (A) | — | $0 | EDGAR |
| 2025-03-24 | CRSP | Mixed | +9,657 | -$413.6K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.